Justice Department· Rule· 91 FR 55259
Schedules of Controlled Substances: Placement of Cipepofol in Schedule IV
effective in 0d·comments close in 32d
On May 29, 2026, the United States Food and Drug Administration (FDA) approved a new drug application for Cypsedo (cipepofol) for induction of general anesthesia in adults undergoing surgery. The Department of Health and Human Services provided the Drug Enforcement Administration (DEA) with a scheduling recommendation…
Owner check — Regulated-substance action: affected handlers should confirm licensing, inventory, shipping, and compliance obligations.